Geode Capital Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$831K Buy
127,339
+7,382
+6% +$45.9K ﹤0.01% 3421
2025
Q4
$686K Buy
119,957
+1,123
+0.9% +$6.93K ﹤0.01% 3488
2025
Q3
$811K Buy
118,834
+5,781
+5% +$43.8K ﹤0.01% 3454
2025
Q2
$1.02M Sell
113,053
-125,564
-53% -$744K ﹤0.01% 3321
2025
Q1
$1.28M Buy
238,617
+5,037
+2% +$34.2K ﹤0.01% 3216
2024
Q4
$1.74M Buy
233,580
+899
+0.4% +$7.39K ﹤0.01% 3178
2024
Q3
$2.1M Buy
232,681
+2,835
+1% +$29.2K ﹤0.01% 3113
2024
Q2
$2.44M Buy
229,846
+126,740
+123% +$1.35M ﹤0.01% 3067
2024
Q1
$909K Sell
103,106
-4,104
-4% -$33.4K ﹤0.01% 3402
2023
Q4
$731K Buy
107,210
+4,919
+5% +$40.4K ﹤0.01% 3465
2023
Q3
$999K Sell
102,291
-4,852
-5% -$38.9K ﹤0.01% 3320
2023
Q2
$519K Sell
107,143
-12,666
-11% -$55K ﹤0.01% 3622
2023
Q1
$482K Buy
119,809
+2
+0% +$8 ﹤0.01% 3659
2022
Q4
$462K Sell
119,807
-215
-0.2% -$992 ﹤0.01% 3693
2022
Q3
$577K Buy
120,022
+447
+0.4% +$2.11K ﹤0.01% 3648
2022
Q2
$544K Sell
119,575
-19,998
-14% -$98.5K ﹤0.01% 3718
2022
Q1
$749K Sell
139,573
-20,880
-13% -$112K ﹤0.01% 3746
2021
Q4
$969K Sell
160,453
-1,082
-0.7% -$6.64K ﹤0.01% 3740
2021
Q3
$1.14M Buy
161,535
+14,731
+10% +$119K ﹤0.01% 3613
2021
Q2
$1.23M Sell
146,804
-29,768
-17% -$256K ﹤0.01% 3495
2021
Q1
$1.46M Buy
176,572
+3,795
+2% +$26.9K ﹤0.01% 3403
2020
Q4
$1.12M Buy
172,777
+7,433
+4% +$46.9K ﹤0.01% 3338
2020
Q3
$975K Buy
165,344
+546
+0.3% +$3.59K ﹤0.01% 3221
2020
Q2
$1.16M Buy
164,798
+60,322
+58% +$441K ﹤0.01% 3098
2020
Q1
$543K Hold
104,476
﹤0.01% 3252
2019
Q4
$772K Buy
104,476
+218
+0.2% +$1.81K ﹤0.01% 3361
2019
Q3
$902K Hold
104,258
﹤0.01% 3265
2019
Q2
$828K Buy
104,258
+2,835
+3% +$25.8K ﹤0.01% 3289
2019
Q1
$1.04M Buy
101,423
+30,619
+43% +$275K ﹤0.01% 3147
2018
Q4
$477K Hold
70,804
﹤0.01% 3392
2018
Q3
$577K Buy
70,804
+959
+1% +$8.96K ﹤0.01% 3413
2018
Q2
$670K Buy
69,845
+6,646
+11% +$63.7K ﹤0.01% 3338
2018
Q1
$631K Hold
63,199
﹤0.01% 3314
2017
Q4
$413K Hold
63,199
﹤0.01% 3433
2017
Q3
$426K Hold
63,199
﹤0.01% 3418
2017
Q2
$455K Sell
63,199
-2,641
-4% -$16.2K ﹤0.01% 3388
2017
Q1
$355K Buy
65,840
+360
+0.5% +$1.96K ﹤0.01% 3448
2016
Q4
$324K Buy
65,480
+240
+0.4% +$1.08K ﹤0.01% 3427
2016
Q3
$267K Buy
65,240
+60
+0.1% +$264 ﹤0.01% 3493
2016
Q2
$326K Hold
65,180
﹤0.01% 3397
2016
Q1
$333 Sell
65,180
-60
-0.1% -$325 ﹤0.01% 3427
2015
Q4
$421K Buy
65,240
+4,842
+8% +$32K ﹤0.01% 3354
2015
Q3
$355K Buy
60,398
+120
+0.2% +$536 ﹤0.01% 3391
2015
Q2
$252K Buy
60,278
+60
+0.1% +$244 ﹤0.01% 3505
2015
Q1
$240K Buy
60,218
+180
+0.3% +$622 ﹤0.01% 3510
2014
Q4
$187K Buy
60,038
+180
+0.3% +$553 ﹤0.01% 3605
2014
Q3
$193K Buy
59,858
+120
+0.2% +$412 ﹤0.01% 3586
2014
Q2
$229K Sell
59,738
-60
-0.1% -$230 ﹤0.01% 3472
2014
Q1
$254K Buy
59,798
+180
+0.3% +$691 ﹤0.01% 3424
2013
Q4
$211K Buy
59,618
+120
+0.2% +$448 ﹤0.01% 3412
2013
Q3
$238K Buy
59,498
+120
+0.2% +$452 ﹤0.01% 3249
2013
Q2
$211K Buy
+59,378
New +$232K ﹤0.01% 3216

Other funds holding ULBI

Geode Capital Management's ULBI Position: Q1 2026 in Review

Geode Capital Management increased its Ultralife (ULBI) stake by 6.2% in Q1 2026, buying an estimated $45.9K and bringing the position to 127,339 shares worth $831K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

Geode Capital Management first reported a position in ULBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.44M in Q2 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Geode Capital Management held 127,339 shares of Ultralife worth $831K as of Q1 2026.
  • Geode Capital Management bought 7,382 Ultralife shares in Q1 2026, an estimated $45.9K.
  • Ultralife made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3421 holding.
  • Geode Capital Management first reported a position in Ultralife in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Ultralife position peaked at $2.44M in Q2 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.